Open AccessMelanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights
Author(s) -
Gil Awada,
Bart Neyns
Publication year - 2022
Publication title -
current opinion in oncology/current opinion in oncology, with cancerlit
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.297
H-Index - 95
eISSN - 1080-8140
pISSN - 1040-8746
DOI - 10.1097/cco.0000000000000817
Subject(s) - melanoma , neuroblastoma ras viral oncogene homolog , mek inhibitor , medicine , vemurafenib , cancer research , targeted therapy , trametinib , mutant , pembrolizumab , v600e , pharmacology , mapk/erk pathway , cancer , immunotherapy , kinase , biology , kras , metastatic melanoma , colorectal cancer , biochemistry , gene , microbiology and biotechnology